Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/27/2003CA2752127A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of hepatocellular carcinoma
11/27/2003CA2752124A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of head and neck cancer
11/27/2003CA2752122A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of ovarian cancer
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2727824A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of solid tumors
11/27/2003CA2494359A1 Bcg vaccine and utilization thereof
11/27/2003CA2489102A1 Use of quinoline derivatives with anti-integrase effect and applications thereof
11/27/2003CA2486801A1 Method of prophylaxis of infection
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003CA2486468A1 Improvements in delivery technology
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003CA2486133A1 Injection formulation
11/27/2003CA2486106A1 Compounds and methods for inhibiting selectin-mediated function
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485502A1 An antimicrobial agent
11/27/2003CA2485465A1 Methods of treating hepatitis
11/27/2003CA2484654A1 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2483770A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003CA2483600A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/27/2003CA2483591A1 Lactams used as anti-viral agents
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2481783A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365024A1 Traf3-binding b cell-specific receptor
11/26/2003EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364944A1 Frangible Compounds for Pathogen Inactivation
11/26/2003EP1364660A1 Drug-releasing system of biodegradable polymer type
11/26/2003EP1364653A1 Casoase 3 inhibitors
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363934A1 Template-fixed peptidomimetics with antimicrobial activity
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363927A2 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
11/26/2003EP1363925A1 Macrolide antibiotics
11/26/2003EP1363924A1 Avilamycin derivatives
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363907A2 Heterocycle carboxamides as antiviral agents
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363904A1 Pyrazoles as tgf inhibitors
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363877A2 Benzophenones as inhibitors of reverse transcriptase
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003EP1363704A2 Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor
11/26/2003EP1363703A2 Disease prevention by reactivation of the thymus
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363671A2 Water-soluble compositions of bioactive lipophilic compounds
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363661A2 Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
11/26/2003EP1363651A1 Herbal compositions useful as chemopreventive and therapeutic agents
11/26/2003EP1363650A2 AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING i PIMENTA /i EXTRACT
11/26/2003EP1363647A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363626A1 Antifungal remedy formulation for external application
11/26/2003EP1363623A2 Peptide deformylase inhibitors
11/26/2003EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
11/26/2003EP1363617A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue
11/26/2003EP1363616A1 Carboxylic acid such as citric acid for disinfecting or enhancing the production of blood products such as plasma, cryoprecipitate or/and platelet
11/26/2003EP1363612A2 Peptide deformylase inhibitors
11/26/2003EP1363611A1 Retinoid hepatitis therapy
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1259523B1 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/26/2003EP1202987B1 Quinoline derivatives and their use as antibacterial agents
11/26/2003EP1037614B1 A double capsule for the administration of active principles in multiple therapies
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP1007528B1 Robustaflavone, intermediates and analogues and method for preparation thereof
11/26/2003EP0964687B1 Pharmaceutical compositions with antimicrobial activity
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components
11/26/2003CN1458932A 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acid derivatives as anti-bacterial agents
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458847A Preparation for enhancement of action of anti-infective agent and method
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458844A Method of using diketopiperazines and composition containing them
11/26/2003CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
1 ... 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 ... 1798